Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elena N. Misyurina"'
Autor:
Elena A. Baryakh, Olga L. Kochneva, Elena N. Misyurina, Evgenia I. Zhelnova, Konstantin V. Yatskov, Alena I. Zagrebneva, Rushan R. Zyangirov, Inna V. Samsonova, Natalia G. Poteshkina, Mariana A. Lysenko, Irina V. Poddubnaya
Publikováno v:
Современная онкология, Vol 22, Iss 2, Pp 74-78 (2020)
Justification. Oncological diseases, along with diabetes, hypertension, cardiovascular and chronic obstructive pulmonary diseases, are associated with severe course and worst prognosis of the new coronavirus infection COVID-19. Due to the limited num
Externí odkaz:
https://doaj.org/article/50904b24199748a6bb5bbcb279ee0fe2
Autor:
Yusef N Yusef, Elena N Misyurina, Diana V Andzhelova, Mayya V Vorobyeva, Elina E Kazaryan, Tatyana V Smirnova, Elena A Baryah, Ainura B Makeshova, Tatyana N Tolstykh
Publikováno v:
HemaSphere, Vol 7, p e1299742 (2023)
Externí odkaz:
https://doaj.org/article/5756225b83aa4c4e90d236da6690b598
Autor:
Diana D. Ivanova, Konstantin V. Yatskov, Yuri Yu. Polyakov, Ksenia V. Kaluzhskaya, Inna V. Samsonova, M.A. Lysenko, Tatyana S. Chudnova, Denis A. Fedorenko, Eduard G. Gemdzhian, Olga L. Kochneva, E A Baryakh, Elena N. Misyurina, Evgenia I. Zhelnova
Publikováno v:
Blood
Background: According to published data, the risk of coronavirus infection (COVID-19) in patients with malignancies is 5 times higher than in those without malignancies. Objective: To evaluate in-hospital overall survival in hematological patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ce43367605cb229772effd77ee1eaaa
http://europepmc.org/articles/PMC8701418
http://europepmc.org/articles/PMC8701418
Autor:
Elena N. Misyurina, Aminat U. Magomedova, T N Obukhova, N G Poteshkina, Alla M. Kovrigina, A E Misyurina, B V Zingerman, E A Baryakh, S K Kravchenko, M.A. Lysenko, Vorob'ev Ai
Publikováno v:
Современная онкология, Vol 18, Iss 5, Pp 22-30 (2016)
Purpose. The identifying of the clinical, morphological, immunophenotypic and cytogenetic features of double-hit and double-expressor lymphomas as well as the development of optimal tactics of treatment and evaluation of efficiency of the ASCT were t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f260b4fbdec996682f38e802dd2b05e7
https://modernonco.orscience.ru/1815-1434/article/view/27106
https://modernonco.orscience.ru/1815-1434/article/view/27106
Autor:
Mironov Oleg I, Elena Volodicheva, Raisa Minullina, Elena G. Smirnova, Gulnara Husainova, Tatyana Ionova, Tatiana Shelekhova, Olga Larionova, Vyacheslav Kurakin, Oksana Kaverina, Iurii Osipov, Alim Amdiev, Mikhail Yu Volkov, NE Mochkin, N. Mikhailova, V. E. Ivanov, Natalia Trenina, Dmitrij Sherstnev, Oleg Rykavitcin, Tatiana Nikitina, Polina Simashova, E A Baryakh, Viktor Chang, Kirill V. Lepik, Darya Lazareva, Boris V. Afanasiev, Evgeniy V. Vasiliev, Elena N. Misyurina, Irina Lysenko, Maria Andrievskih, K D Kaplanov, Tatiana Klitochenko, Rustem Safin, Tatiana V. Petrova, Natalia Porfirieva
Publikováno v:
Blood. 134:5296-5296
There is a continued unmet medical need in pts with relapsed/refractory Hodgkin's lymphoma (RR HL). Curing HL pts who have refractory disease after salvage chemotherapy, who relapse after ASCT, or those who are not candidates for ASCT, remains a clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::852fbc2b794b614e5d87a8b7e8011b31
https://doi.org/10.1182/blood-2019-121997
https://doi.org/10.1182/blood-2019-121997
Autor:
Laura Kesaeva, A. V. Misyurin, Elena N Misyurina, Elena Aksenova, Anna G. Turkina, Elena N. Parovichnikova, Valeri G. Savchenko, Ekaterina Chelysheva, Irina Soldatova, Alexey Krutov
Publikováno v:
Blood. 118:4420-4420
Abstract 4420 In the period from 18.01.06 to 25.05.11 we have performed mutation analysis in CML pts with the obvious manifestation of resistance against imatinib. Chronic phase CML patients have been treated by imatinib and monitored by means of RQ-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::482a93ebd2f321acbce24eb2e178783a
https://doi.org/10.1182/blood.v118.21.4420.4420
https://doi.org/10.1182/blood.v118.21.4420.4420